Airway Clearance Devices Market

Airway Clearance Devices Market Size

The global airway clearance devices market size was valued at USD 648.6 million in 2023 and is expected to exhibit growth at a CAGR of 4.8% from 2024 to 2032 period. The market is expected to grow significantly over the upcoming years due to increasing respiratory infections, rising geriatric population coupled with increase in chronic diseases, and increasing air pollution which further increases the diseases burden.

Increasing cases of respiratory diseases such as rising number of COPD, cystic fibrosis, asthma, and other chronic respiratory diseases, increases the demand for airway clearance diseases. According to the WHO, COPD has become the fourth major cause of death worldwide with, 3.5 million deaths in 2021, about 5% of total deaths. Such diseases are thought to augment airway secretions which obstruct breathing as well as to diminish the quality of life.

Such increasing prevalence of respiratory diseases boosts market growth.  The increasing elderly population that suffers from multiple respiratory diseases is another factor for the increasing demand of airway clearance devices. In addition, the improvement of airway clearance device technologies such as more effective, easier to use, and portable devices results in better acceptance among patients and clinicians, further fostering the market expansion.

Airway clearance devices are mechanized medical tools capable of collecting and discharging fluid mucus and other material blockages impeding breathing processes in individuals who have trouble with respiration. People suffering from certain chronic lung diseases like cystic fibrosis, COPD, and bronchiectasis depend on such devices.

Airway Clearance Devices Market Trends

The expansion of the market for airway clearance devices is largely driven by the growing cases of respiratory disorders worldwide.

• There has been a global escalation in the burden of chronic respiratory conditions like COPD, asthma, cystic fibrosis, and bronchiectasis, which has resulted in a greater demand for management and treatment.
  
• In terms of overall numbers, the Global Burden of Disease Study estimated that in 2019, there were 262 million people affected by asthma.
  
• Increasing use of airway clearance devices which remove excess mucus for the improved lung function and respiratory fitness is becoming more significant in the management of these chronic diseases.
  
• Simultaneously, with the increase in age of the population, respiratory ailments are on the rise due to increased contact with allergens and environmental contamination which has further increased the demand for superior airway clearance technologies to improve patient care and quality of life.
  
• Moreover, the escalation in government expenditure focusing on treatment of respiratory ailments is triggering growth in the market.
  
• Public health initiatives targeting early diagnosis, better prevention strategies, and effective management of respiratory diseases have also led to the heightened adoption of airway clearance devices resulting in further expansion of the market. 
  

Airway Clearance Devices Market Analysis

Based on the device type, the market is classified into high frequency chest wall oscillation (HFCWO), flutter mucus clearance device, intrapulmonary percussive ventilation (IPV), mechanical cough assist devices, positive expiratory pressure (PEP), and other device types. The high frequency chest wall oscillation (HFCWO) segment generated the highest revenue of USD 242.6 million in 2023.

• HFCWO devices provide a valuable alternative to the traditional techniques of airway clearance by shifting focus from invasive methods to noninvasive techniques. Patients with mobility limitations, particularly elderly and small children, are able to utilize these devices with minimal supervision which drives their adoption rates higher.
  
• Additionally, these devices are equipped with therapy settings that can be customized to the patients’ needs along with portability and wireless connectivity which increases patients’ adherence to the treatment. Further improvements such as ergonomic designs and noise canceling features provide patients with a better overall experience.
  

Based on the application, the airway clearance devices market is classified into COPD, bronchiectasis, cystic fibrosis, neuromuscular, and other applications. COPD segment dominated the market in 2023 with a market share of 42.1%.

• The segment is propelled by the escalating global burden of COPD which is responsible for significant rates of morbidity and mortality around the globe. Increased consumption of tobacco, exposure to environmental pollutants, occupational injuries, and population aging are some of the reasons responsible for the increased load of COPD.
  
• WHO estimates that millions of people have moderate to severe COPD, hence there is a tremendous need for airway clearance management devices for symptom management and improving health-related quality of life.
  
• Moreover, COPD is also associated with overproduction of mucus and under functioning of the mucociliary apparatus leading to airway obstruction and exacerbations of the disease. Various airway clearance devices including OPEP and HFCWO devices are particularly useful in eliminating mucus pluggins, which alleviates respiratory problems. These factors are expected to promote segmental growth.
  

Based on age group, the airway clearance devices market is segmented into adult and pediatric. The adult segment dominated the market in 2023 and is anticipated to reach USD 654 million by the end of forecast period.

• The increased prevalence of adults living with chronic diseases such as cystic fibrosis, COPD and bronchiectasis is influencing the growth for airway clearance devices. The older population is more susceptible to respiratory problems which increases the dependency on such devices and subsequently improves the quality of life.
  
• Also, innovation in airway clearance devices like portable and easy to operate systems is making these devices more attractive to the adult population. 
  
• Lastly, with improved infrastructure and access to insurance, a larger population of adults have the ability to afford these airway clearance devices, enhancing their market share. 
  

Based on end use, the airway clearance devices market is segmented into hospital, homecare settings, ambulatory surgical centers, and other end users. The homecare settings segment dominated the market in 2023 and is anticipated to reach USD 540.5 million by the end of forecast period.

• The increasing adoption of homecare by patients since it is affordable and convenient has caused an increase in the demand for airway clearance devices to be used within the home setting.
  
• Furthermore, airway clearance devices are now made ergonomic and smaller and are more efficient for use in the home setting. This has resulted in a more rapid adoption of the devices in homecare.
  
• Lastly, availability of insurance coverage for home use airway clearance devices, further strengthens the segmental growth.
  

North America airway clearance devices market accounted for USD 254.6 million market revenue in 2023 and is anticipated to grow at a CAGR of 3% between 2024 to 2032 period.

• There is a rising prevalence of chronic lung diseases like COPD, asthma, and cystic fibrosis in the region, which results in increased demand for airway clearance devices for preventing or managing these conditions.
  
• Also, a high adoption of airway clearance devices in countries such as the U.S. enhances the regional market growth. Furthermore, greater access to these airway clearance devices owing to the reimbursement policies for respiratory treatments, both under Medicare and Medicaid, fuels the market growth.
  
• Lastly, owing to the presence of major manufacturers and distributors of the equipment and a large network of healthcare practitioners and institutions, airway clearance devices are easily accessible in the region.
  

Germany airway clearance devices market is projected to grow remarkably in the coming years.

• Respiratory diseases like COPD and cystic fibrosis are on the rise in Germany, leading to a growing market for airway clearance devices for treatment and management of such conditions.
  
• Germany’s advanced healthcare system and well-developed medical facilities enhance the use and use of airway clearance devices, which aids market development.
  
• Reinforcing policies from the government such as mobilization of funds to aid reimbursement for respiratory treatments further increases the market for airway clearance devices in the country.
  

China holds a dominant position in the Asia Pacific airway clearance devices market.

• High population of China and its high rate of respiratory illnesses like chronic obstructive pulmonary disease and cystic fibrosis greatly increases the need for airway clearance devices.
  
• The Chinese government’s investment in the healthcare sector and policies strengthens the adoption of advanced medical technologies like airway clearance devices. 
  
• There is also a rise in awareness for chronic respiratory diseases and their home-based treatment in China leading to an increase in the use of airway clearance devices at home. All these factors together contribute to the country’s strong growth in the Asia Pacific market.
  

Airway Clearance Devices Market Share

The market is highly competitive one with several key market players operating in the industry. Key participants such as Baxter International/Hill-Rom Holdings, Koninklijke Philips N.V., and Electromed hold an edge over the competitors as they manufacture and supply a range of products such as HFCWO systems, PEP devices and mechanical insufflation-exsufflation devices. All these firms are focusing more on R&D to create more efficient, lighter, and easier-to-operate devices due to the rising rates of chronic respiratory diseases. Additionally, as the focus turns towards homecare, the companies are focussing on product design and economical pricing to cater to this segment.

Airway Clearance Devices Market Companies

Prominent players operating in the airway clearance devices industry include:

• ABM Respiratory Care
• Baxter International/Hill-Rom Holdings
• Dima Italia
• Dymedso
• Electromed
• ICU Medical
• Koninklijke Philips N.V.
• Mercury Medical
• Monaghan Medical
• Pari Medical
• Pneumo Care Health
• Sentec
• Tactile Medical
• Thayer Medical
• VORTRAN Medical
• VYAIRE MEDICAL
  

USPs of top players

• Different companies strive to be unique by adding new technologies, such as HFCWO, OPEP, and vibratory PEP systems, which help with more effective mucus clearance methods.
  
• The top brands focus on production of user-friendly non-invasive devices that are portable, easy to operate, and very quiet, hence increasing patient compliance and acceptance.
  

Airway Clearance Devices Industry News:

• In April 2023, Monaghan Medical and Premier Inc. signed an agreement to provide respiratory devices to clinicians. Under the agreement Monaghan will provide Premier members with respiratory devices in two categories: Respiratory Therapy Medication Delivery devices and Oscillatory Positive Expiratory Pressure/Positive Airway Pressure devices. This agreement may help the company to enhance its presence in the market and enhance their customer base.
  
• In January 2022, ICU Medical Inc. announced the acquisition of Smiths Medical from Smiths Group plc, a manufacturer of respiratory management devices and advanced medical devices. This acquisition helped the company to increase their product portfolio and acquire a new customer base.
  

The airway clearance devices market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Device Type

• High frequency chest wall oscillation (HFCWO)
• Flutter mucus clearance device
• Intrapulmonary percussive ventilation (IPV)
• Mechanical cough assist devices
• Positive expiratory pressure (PEP)
• Other device types

Market, By Application

• Chronic obstructive pulmonary disease (COPD)
• Bronchiectasis
• Cystic fibrosis
• Neuromuscular
• Other applications

Market, By Age Group

• Adult
• Pediatric

Market, By End Use

• Hospital
• Homecare settings
• Ambulatory surgical centers
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE